A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells

Journal of Clinical Investigation

Volumn 104, Issue 11, 1999, Pages 1539-1547

  Itoh, Hiroshi ^a   Beck, Paul L ^a   Inoue, Nagamu ^a   Xavier, Ramnik ^a   Podolsky, Daniel K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE;

ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL LINEAGE; COLON INJURY; CONTROLLED STUDY; GENE SEQUENCE; GOBLET CELL; INTESTINE MUCOSA; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033454060     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6211     Document Type: Article

References (42)

1. Allen, A., Hutton, D.A. Leonard, A.J., Pearson, J.P., and Sellers, L.A. 1986. The role of mucus in the protection of the gastroduodenal mucosa. Scand. J. Gastroenterol. 21:71-77.
2. Owen, D.A., and Kelly, J.K. 1995. Inflammatory diseases of the gastrointestinal tract. Mod. Pathol. 8:97-108.
3. Filipe, M.I. 1979. Mucins in the human gastrointestinal epithelium: a review. Invest. Cell Pathol. 2:195-216.
4. Specian, R.D., and Oliver, M.G. 1991. Functional biology of intestinal goblet cells. Am. J. Physiol. 260:C183-C193.
5. Verma, M., and Davidson, E.A. 199-4. Mucingenes: structure, expression and regulation. Glycoconj. J. 11:172-179.
6. Breitman, M.L., et al. 1987. Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science. 238:1563-1565.
7. Palmiter, R.D., et al. 1987. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell. 50:435-443.
8. Li, Q., Karam, S.M., and Gordon, J.I. 1996. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J. Biol. Chem. 271:3671-3676.
9. Garabedian, E.M., Roberts, L.J., McNevin, M.S., and Gordon, J.I. 1997. Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. J. Biol. Chem. 272:23729-23740.
10. Hermiston, M.L., and Gordon, J.I. 1995. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 270:1203-1207.
11. Playford, R.J., et al. 1996. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl Acad. Sci. USA. 93:2137-2142.
12. Suemori, S., Lynch-Devaney, K., and Podolsky, D.K. 1991. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc. Natl. Acad. Sci. USA. 88:11017-11021.
13. Podolsky, D.K., et al. 1993. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J. Biol. Chem. 268:6694-6702.
14. Babyatsky, M.W. deBeaumont, M., Thim, L., and Podolsky, D.K. 1996. Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology. 110:489 497.
15. Mashimo, H., Wu, D.C., Podolsky, D.K., and Fishman, M.C. 1996. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 274:262-265.
16. Ogata, H., Inoue, N., and Podolsky, D.K. 1998. Identification of a goblet cell-specific enhancer element in the rat intestinal trefoil factor gene promoter bound by a goblet cell nuclear protein. J. Biol. Chem. 273:1060-3067.
17. Itoh, H., Inoue, N., and Podolsky, D.K 1999. Goblet cell-specific transcription of mouse intestinal trefoil factor gene results from collaboration of distinctive positive and negative regulatory elements. Biochem. J. 341:461-472.
18. Maxwell, H., Maxwell, I.H., and Glode, L.M. 1987. Cloning, sequence determination, and expression of transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain. Mol. Cell. Biol. 7:1576-1579.
19. Breitman, M.L., Rombola, H., Maxwell, I.H., Klimworth, G.K., and Bernstein, A. 1990. Genetic ablation in transgenic mice with an attenuated diphtheria toxin A gene. Mol. Cell. Biol. 10:474-479.
20. Evans, G.A. 1989. Disserting mouse development with toxigenics Dev. 3:259-263.
21. Gordon, J.W. 1993. Production of transgenic mice. Methods Enzymol. 225:747-771.
22. Maniatis, T., Fritsch, E.F., and Sambrook, J. 1989. Molecular cloning: a laboratory manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 9.16-9.19.
23. Tomita, M., et al. 1995. Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. Biochem. J. 311:293-297.
24. Itoh, H., et al. 1996. cDNA cloning of rat pS2 peptide and expression of trefoil peprides in acetic acid-induced colitis. Biochem. J. 318:939-944.
25. Xu, G., et al. 1992. cDNA for the carboxyl-terminal region of a rat intestinal mucin-like peptide. J. Biol. Chem. 267:5401-5407.
26. Shekels, L.L., et al. 1998. Cloning and characterization of mouse intestinal MUC3 mucin: 3′ sequence contains epidermal-growth-factor-like domains. Biochem. J. 330:1301-1308.
27. Ogata, H., and Podolsky, D.K. 1997. Trefoil peptide expression and secretion is regulated by neuropeptides and acetylcholine. Am. J. Physiol. 273:G348-G354.
28. Okayasu, I., et al. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98:694-702.
29. Egger, H., et al. 1997. Mice lacking transforming growth factor alpha have an increased susceptibility to dextrin sulfate-induced colitis. Gastroenterology. 113:825-832.
30. MacPherson, B.R., and Pfeiffer, C.J. 1978. Experimental production of diffuse colitis in rats. Digestion. 17:135-150.
31. Gordon, J.I. 1999. Intestinal epithelial differentiation: new insights from chimeric and transgenic mice. J. Cell Biol. 108:1187-1194.
32. Chang, S.K., et al. 1994. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology. 107:28-36.
33. Tytgay, K.M., Opdam, F.J., Einerhand, A.W., Büller, H.A., and Dekker, J. 1996. MUC2 is the prominent colonic mucin expressed in ulcerative colitis. Gut. 38:554-563.
34. Weiss, A.A., Babyatsky, M.W. Ogata, S., Chen, A., and Itzkowitz, S.H. 1996. Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J. Histochem. Cytochem. 44:1161-1166.
35. Wright, N.A., et al. 1993. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 104:12-20.
36. Alison, M.R., et al. 1995. Experimental ulceration leads to sequential expression of spasmolytic polypepride, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J. Pathol. 175:405-414.
37. Morris, G.P., et al. 1989. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 96:795-803.
38. McHugh, K.J., Weingarren, H.P., Keenan, C., Wallace, J.L., and Collins, S.M. 1993. On the suppression of food intake in experimental models of colitis in the rat. Am. J. Physiol. 264:R871-R876.
39. Elson, C.O., et al. 1996. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J. Immunol. 157:2174-2185.
40. Sadlack, B., et al. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:253-261.
41. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. 1993. Interleukin-10-deficient mice develop chronic enrerocolitis. Cell. 75:263-274.
42. Mombaerts, P., et al. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:275-282.